Healthcare

Vascular Stent Market Penetration, Adoption, Lighting Technology, Refurbishment, Passenger Comfort And Forecast 2023-2032|Medtronic Plc., Abbott Laboratories, Boston Scientific Corporation, Biotronik, B. Braun (B. Braun Melsungen)

Realistic blood vessels heart infographic with cardiovascular system venola arteriole capillaries and other descriptions vector illustration

The Vascular Stent Global Market Report 2023 by The Business Research Company, provides vascular stent market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten-year historic period – 2010-2021, and a ten-year forecast period – 2023-2032.

Learn More On The Vascular Stent Market:

https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report

According to The Business Research Company’s Vascular Stent Global Market Report 2023, the global vascular stent market size is expected to grow from $13.42 billion in 2022 to $14.67 billion in 2023 at a compound annual growth rate (CAGR) of 9.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The vascular stent market is expected to grow to $20.53 billion in 2027 at a CAGR of 8.8%.

Rise in the incidence of vascular diseases will propel the growth of the vascular stent market going forward. Vascular disease refers to an abnormal condition that affects the blood vessels (arteries and veins) and is part of the cardiovascular diseases (CVD) group. The vascular stents help in the treatment of various vascular diseases by enabling the supply of oxygen-rich blood to the heart.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=8363&type=smp

The vascular stent market is segmented:

1) By Product: Coronary Stents, Peripheral Vascular Stents, and Evar Stent Grafts

2) By Type: Bare Metal Stent, Bio-Engineered Stent, Bioresorbable Vascular Scaffold, Drug-Eluting Stent, Dual Therapy Stent

3) By Material: Metallic Stents, Cobalt-Chromium, Platinum-Chromium, Nickel-Titanium, Stainless Steel, Polymer Stents

4) By Mode of Delivery: Balloon-expandable Stent, Self-expanding Stent

5) By End-user: Ambulatory Surgical Center, Cardiac Center, Hospital

Technological advancement is a key trend gaining popularity in the vascular stent market. Many companies are investing in bio-sensing devices, cutting-edge integrated stents, and drug-eluting coronary stent systems to gain a competitive edge in the market. For instance, in 2022, Translumina, an India-based medical equipment manufacturer launched VIVO ISAR, a latest generation dual drug polymer-free coated stent (DDCS) that brings together a stent with a superior safety profile without compromising the drug release kinetics. It uses Probucol, an antioxidant and lipid-lowering drug, as a carrier for releasing Sirolimus (an anti-restenosis drug), and thus creates a polymer-free DES platform with uncompromised safety and efficacy.

The vascular stent market report table of contents includes: